DHR vs INTU: Which Is the Better Buy?
Side-by-side comparison of Danaher Corporation and Intuit Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-04.
Danaher Corporation · Healthcare
$174.04
+13.2% upside to fair value
Grade B
VS
Intuit Inc. · Technology
$396.57
+37.7% upside to fair value
High Conviction
Grade A-
QuantHub Verdict
INTU has more upside to fair value
(+37.7%).
INTU trades at a lower forward P/E
(19.5x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DHR |
INTU |
| Current Price |
$174.04 |
$396.57 |
| Fair Value Estimate |
$197.01 |
$546.00 |
| Upside to Fair Value |
+13.2%
|
+37.7%
|
| Market Cap |
$123.2B |
$110.4B |
| Forward P/E |
33.4x
|
19.5x
|
| EV / EBITDA |
20.3x
|
19.0x
|
| Price / Sales |
5.0x
|
5.9x
|
| Price / FCF |
23.3x
|
18.1x
|
| Revenue Growth YoY |
+3.7%
|
+15.6%
|
| Gross Margin |
60.7%
|
80.8%
|
| Operating Margin |
21.0%
|
26.1%
|
| Return on Equity |
7.1%
|
19.6%
|
| Dividend Yield |
0% |
1.17% |
| FCF Yield |
4.3%
|
5.51%
|
| Analyst Consensus |
Strong Buy
|
Buy
|
Investment Thesis
Danaher Corporation is a diversified healthcare company focused on medical diagnostics, life sciences, and biotechnology, generating approximately $24 billion in revenue with a strong recurring revenue base of over 81%. The company benefits from a high gross margin of 60.7% and solid operating margin of 21%, supported by a seasoned management team with a proven capital allocation track record inc…
Intuit is a near-monopoly financial operating system for 60+ million American households and small businesses. TurboTax handles 40%+ of US e-filed returns; QuickBooks is so deeply embedded in SMB workflows it has become the default accounting standard. The stock has fallen 51% from its 2025 high as markets price in AI disruption that has not materialized at scale and may not, since tax complexity…
Accumulation Zones
| Metric |
DHR |
INTU |
| Zone Low |
$147.76 |
$410.00 |
| Zone High |
$167.46 |
$464.00 |
| In Buy Zone? |
No
|
Yes
|